{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:11:36Z","timestamp":1780463496192,"version":"3.54.1"},"reference-count":38,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1191821"],"award-info":[{"award-number":["OPP1191821"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,2,28]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>The 2021 importation of wild poliovirus serotype 1 (WPV1) into Malawi with subsequent international spread represented the first WPV1 cases in Africa since 2016. Preventing importations and spread of WPV1 is critical and dependent on population immunity provided through routine immunisation (RI) and supplementary immunisation activities (SIAs). We aim to estimate outbreak risk and costs, given the importation of WPV1 for non-endemic countries in the WHO Africa region. We developed a stochastic mathematical model of polio transmission dynamics to evaluate the probability of an outbreak, expected number of poliomyelitis cases, costs and incremental cost-effectiveness ratios under different vaccination strategies. Across variable RI coverage, we explore three key strategies: RI+outbreak SIAs (oSIAs), RI+oSIAs+annual preventative SIAs (pSIAs) and RI+oSIAs+biennial pSIAs. Results are presented in 2023 USD over a 5year- time horizon from the Global Polio Eradication Initiative (GPEI) and health system perspectives. The annual pSIA strategy has the greatest probability of no outbreaks in comparison to other strategies: under our model assumptions, annual pSIAs result in an 80% probability of no outbreaks when RI coverage is \u226550%. The biennial pSIA strategy requires RI coverage \u226565%\u2009to achieve an equivalent risk of no outbreaks. The strategy with no pSIAs requires \u226575%\u2009RI coverage to achieve an equivalent risk of no outbreaks. For the health system, when RI coverage is between 35% and 60%, both pSIA strategies are cost-saving. For the GPEI, below 65% RI pSIA strategies are cost-effective, but the biennial pSIA strategy incurs higher costs in comparison to annual pSIAs due to more oSIAs required to stop outbreaks. Prioritisation of pSIAs must balance outbreak risk against implementation costs, ideally favouring the smallest manageable outbreak risk compatible with elimination. We infer that there are few short-term risks due to population immunity from RI, but without pSIAs, long-term risks accumulate and can result in outbreaks with the potential for international spread.<\/jats:p>","DOI":"10.1136\/bmjgh-2024-016013","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T01:32:29Z","timestamp":1742779949000},"page":"e016013","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-4485","authenticated-orcid":false,"given":"Megan","family":"Auzenbergs","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1576","authenticated-orcid":false,"given":"Kaja","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"Nagasaki University School of Tropical Medicine and Global Health, Nagasaki, Japan"},{"name":"Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey M","family":"Peak","sequence":"additional","affiliation":[{"name":"The Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Voorman","sequence":"additional","affiliation":[{"name":"Institute for Disease Modeling, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"2025073015203333000_10.3.e016013.1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6718a4"},{"key":"2025073015203333000_10.3.e016013.2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.15585\/mmwr.mm7123a3","article-title":"Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection - Malawi, February 2022","volume":"71","author":"Davlantes","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025073015203333000_10.3.e016013.3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.15585\/mmwr.mm7341a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024","volume":"73","author":"Namageyo-Funa","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025073015203333000_10.3.e016013.4","unstructured":"Global Polio Eradication Initiative . Expenditure report 2022. 2022. Available: https:\/\/polioeradication.org\/wp-content\/uploads\/2023\/06\/GPEI_2022_Expenditure_Report.pdf"},{"key":"2025073015203333000_10.3.e016013.5","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2022.03.013","article-title":"Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine","volume":"41","author":"Voorman","year":"2023","journal-title":"Vaccine (Auckl)"},{"key":"2025073015203333000_10.3.e016013.6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vaccine.2010.10.026","article-title":"Economic analysis of the global polio eradication initiative","volume":"29","author":"Duintjer Tebbens","year":"2010","journal-title":"Vaccine (Auckl)"},{"key":"2025073015203333000_10.3.e016013.7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"The Lancet"},{"key":"2025073015203333000_10.3.e016013.8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz488"},{"key":"2025073015203333000_10.3.e016013.9","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.122192"},{"key":"2025073015203333000_10.3.e016013.10","doi-asserted-by":"publisher","DOI":"10.3402\/gha.v6i0.19923"},{"key":"2025073015203333000_10.3.e016013.11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/risa.13471","article-title":"Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal"},{"key":"2025073015203333000_10.3.e016013.12","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2023.04.037","article-title":"Outbreak management strategies for cocirculation of multiple poliovirus types","volume":"41","author":"Kalkowska","year":"2023","journal-title":"Vaccine (Auckl)"},{"key":"2025073015203333000_10.3.e016013.13","unstructured":"Global Polio Eradication Initiative . Investment case 2022\u20132026. Geneva, Switzerland World Health Organization; 2022."},{"key":"2025073015203333000_10.3.e016013.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"2025073015203333000_10.3.e016013.15","unstructured":"Global Polio Eradication Initiative . Standard operating procedures: responding to a poliovirus event or outbreak 2022, version 4. 2022. Available: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/04\/Standard-Operating-Procedures-For-Responding-to-a-Poliovirus-Event-Or-Outbreak-20220417_OBR_SOP_final_pre_pub_website.pdf"},{"key":"2025073015203333000_10.3.e016013.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1323688111"},{"key":"2025073015203333000_10.3.e016013.17","unstructured":"World Health Organization, Global Polio Eradication Initiative . Polio eradication strategy 2022\u20132026: delivering on a promise. 2021."},{"key":"2025073015203333000_10.3.e016013.18","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt203"},{"key":"2025073015203333000_10.3.e016013.19","unstructured":"World Health Organization . Poliomyelitis vaccination coverage. 2022. Available: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/poliomyelitis-vaccination-coverage [Accessed 12 Dec 2023]."},{"key":"2025073015203333000_10.3.e016013.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113538","article-title":"Quantifying the impact of expanded age group campaigns for polio eradication","volume":"9","author":"Wagner","year":"2014","journal-title":"PLoS One"},{"key":"2025073015203333000_10.3.e016013.21","doi-asserted-by":"crossref","unstructured":"Widgren S , Bauer P , Eriksson R , et al . SimInf: An R package for data-driven stochastic disease spread simulations. arXiv 2016. doi:10.18637\/jss.v091.i12","DOI":"10.32614\/CRAN.package.SimInf"},{"key":"2025073015203333000_10.3.e016013.22","first-page":"22","article-title":"The principles of disease elimination and eradication","volume":"76 Suppl 2","author":"Dowdle","year":"1998","journal-title":"Bull World Health Organ"},{"key":"2025073015203333000_10.3.e016013.23","unstructured":"World Health Organization . Poliomyelitis. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/poliomyelitis [Accessed 15 Jun 2023]."},{"key":"2025073015203333000_10.3.e016013.24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.EDE.0000058920.38635.D3","article-title":"Long-term mortality after poliomyelitis","volume":"14","author":"Nielsen","year":"2003","journal-title":"Epidemiology"},{"key":"2025073015203333000_10.3.e016013.25","unstructured":"World Health Organization . The global burden of disease: 2004 update. 2008."},{"key":"2025073015203333000_10.3.e016013.26","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025073015203333000_10.3.e016013.27","unstructured":"World Health Organization . WHO guide for standardization of economic evaluations of immunization programmes, 2nd edition. 2019. Available: https:\/\/www.who.int\/publications\/i\/item\/who-guide-for-standardization-of-economic-evaluations-of-immunization-programmes-2nd-ed [accessed 03 Jan 2024]"},{"key":"2025073015203333000_10.3.e016013.28","unstructured":"UNICEF . Inactivated polio vaccine (IPV) price data. 2023. Available: https:\/\/www.unicef.org\/supply\/media\/16266\/file\/IPV-vaccine-prices-14032023.pdf"},{"key":"2025073015203333000_10.3.e016013.29","unstructured":"UNICEF . Oral polio vaccine price data. 2022. Available: https:\/\/www.unicef.org\/supply\/media\/12671\/file\/oral-polio-vaccine-price-data-08062022.pdf"},{"key":"2025073015203333000_10.3.e016013.30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/risa.13664","article-title":"Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal"},{"key":"2025073015203333000_10.3.e016013.31","unstructured":"Guidance note on cold chain logistics and vaccine management during polio supplementary immunization activities. New York, NY UNICEF; 2015."},{"key":"2025073015203333000_10.3.e016013.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100032","article-title":"Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine","volume":"2","author":"Mvundura","year":"2019","journal-title":"Vaccine X"},{"key":"2025073015203333000_10.3.e016013.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.14.1696"},{"key":"2025073015203333000_10.3.e016013.34","unstructured":"Global Polio Eradication Initiative . GPEI calls for renewed commitments to achieve promise of a polio-free world 2022. n.d. Available: https:\/\/polioeradication.org\/news-post\/global-polio-eradication-initiative-calls-for-renewed-commitments-to-achieve-promise-of-a-polio-free-world\/"},{"key":"2025073015203333000_10.3.e016013.35","unstructured":"World Health Organization . Macroeconomics and health: investing in health for economic development. In: Report of the Commission on Macroeconomics and Health. Geneva, 2001. Available: http:\/\/apps.who.int\/iris\/bitstream\/10665\/42435\/1\/924154550X.pdf"},{"key":"2025073015203333000_10.3.e016013.36","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.15.164418"},{"key":"2025073015203333000_10.3.e016013.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2025073015203333000_10.3.e016013.38","doi-asserted-by":"publisher","DOI":"10.1007\/s11127-006-9079-z"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:20:40Z","timestamp":1753914040000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,22]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjgh-2024-016013"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016013","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}